Medicare Enrolled
Dr. Samson Mebrahtu, M.D.
Neurology · Bay Shore, NY
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Mebrahtu from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Mebrahtu?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Mebrahtu
Dr. Samson Mebrahtu is a neurology specialist in Bay Shore, NY, with 20 years of NPI registration. Based on federal Medicare data, Dr. Mebrahtu performed 2,569 Medicare services across 1,633 unique beneficiaries.
Between the years covered by Open Payments, Dr. Mebrahtu received a total of $3,898 from 52 pharmaceutical and/or device companies across 198 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Mebrahtu is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 17% volume in NY
$3,898 industry payments
Medicare Practice Summary
Medicare Utilization ↗2,569
Medicare services
Top 17% in NY for neurology
1,633
Unique beneficiaries
$110
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~128 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Electromyography of arm or leg muscles A test that measures the electrical activity in the muscles of the arm or leg using a needle electrode. It helps evaluate the health of muscles and the nerve cells that control them. |
508 | $94 | $450 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
377 | $17 | $85 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
166 | $55 | $364 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
166 | $111 | $487 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
145 | $152 | $505 |
| Awake and drowsy EEG A test that records electrical activity in the brain while the patient is awake and drowsy. |
135 | $359 | $1,271 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
127 | $110 | $526 |
| Nerve conduction studies, 11-12 A diagnostic test that measures how well nerves send electrical signals. It involves performing 11 to 12 separate nerve conduction studies. |
115 | $226 | $1,270 |
| Autonomic nervous system function test This test evaluates how well the sympathetic nervous system is functioning. It assesses the automatic control of bodily processes such as heart rate and blood pressure. |
95 | $117 | $665 |
| Injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mg | 90 | $0 | $1 |
| Nerve conduction study, 9-10 studies A diagnostic test that measures how well nerves send electrical signals. It involves performing 9 to 10 separate nerve conduction studies to evaluate nerve function. |
76 | $194 | $1,025 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
73 | $160 | $1,156 |
| Electrocardiogram, 1-3 leads with physician review A heart rhythm test using one to three electrodes to record electrical activity, with interpretation by a physician. |
65 | $12 | $47 |
| Visual evoked potential test A test that measures how quickly electrical signals travel from the eye to the brain in response to visual stimuli. |
64 | $54 | $525 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
56 | $76 | $176 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
49 | $142 | $957 |
| Computerized hearing test with interpretation A hearing test that uses a probe to measure sound responses, followed by a professional review and written report of the results. |
47 | $19 | $263 |
| New patient office visit, complex (60-74 min) | 44 | $191 | $596 |
| Nerve conduction studies, 13 or more A diagnostic test that measures how well nerves send electrical signals. This code applies when 13 or more individual nerve studies are performed. |
41 | $263 | $1,521 |
| Auditory brainstem response test A test that measures how the brain responds to sound to help diagnose nervous system disorders. The results are interpreted and reported by a medical professional. |
34 | $80 | $565 |
| Nerve conduction studies, 5-6 tests A series of 5 to 6 tests that measure how well nerves send electrical signals. The procedure evaluates nerve function and helps identify damage or dysfunction. |
26 | $126 | $698 |
| Nerve conduction studies, 7-8 tests A series of 7 to 8 nerve conduction tests to evaluate how well nerves are sending signals to muscles. |
19 | $164 | $961 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
14 | $73 | $493 |
| Brain response to sound test for hearing status A test that measures the brain's electrical response to sound to determine hearing status. The results are interpreted and reported by a medical professional. |
13 | $68 | $375 |
| Placement of skin electrodes and measurement of stimulated sites on arms and legs This procedure involves placing skin electrodes and measuring stimulated sites on the arms and legs. |
13 | $340 | $1,427 |
| Ultrasound of head and neck blood flow, bilateral An ultrasound exam that uses sound waves to visualize and assess blood flow in the vessels of both the head and the neck. |
11 | $163 | $565 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
21.1% high complexity
9.2% medium
69.7% routine
Industry Payment Transparency
Open Payments through 2024 ↗$3,898
Total received (2018-2024)
Avg $557/year across 7 years
Top 37% in NY for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
52
Companies
198
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$3,898 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$35
2023
$343
2022
$841
2021
$710
2020
$306
2019
$783
2018
$880
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Alexion Pharmaceuticals, Inc.
$35
Top 3 companies account for 100.0% of 2024 payments
All-time payments by company (2018-2024) ›
Novartis Pharmaceuticals Corporation
$457
Alexion Pharmaceuticals, Inc.
$378
UCB, Inc.
$315
Amgen Inc.
$286
Braemar Manufacturing, LLC
$232
Lundbeck LLC
$176
Adamas Pharmaceuticals, Inc.
$145
Neurelis, Inc.
$141
Bausch Health US, LLC
$116
Eisai Inc.
$114
ABBVIE INC.
$105
Allergan, Inc.
$88
AbbVie Inc.
$79
ARGENX US, INC.
$79
Neurocrine Biosciences, Inc.
$78
ACADIA Pharmaceuticals Inc
$73
GRT US Holding, Inc.
$69
Ipsen Biopharmaceuticals, Inc
$66
Allergan Inc.
$60
Biohaven Pharmaceutical Holding Company Ltd.
$50
EISAI INC.
$40
Acorda Therapeutics, Inc
$39
Merz North America, Inc.
$38
Avanir Pharmaceuticals, Inc.
$37
Avion Pharmaceuticals
$35
Merz Pharmaceuticals, LLC
$34
Grifols USA, LLC
$33
Horizon Therapeutics plc
$31
W. L. Gore & Associates, Inc.
$31
Sunovion Pharmaceuticals Inc.
$29
Biohaven Pharmaceuticals, Inc.
$29
AstraZeneca Pharmaceuticals LP
$29
EMD Serono, Inc.
$28
PFIZER INC.
$28
MERZ NORTH AMERICA, INC.
$28
GE HEALTHCARE
$24
CSL Behring
$24
Medtronic USA, Inc.
$24
Kyowa Kirin, Inc.
$23
SK Life Science, Inc.
$22
Vertical Pharmaceuticals, LLC
$20
Arbor Pharmaceuticals, Inc.
$19
Amneal Pharmaceuticals LLC
$19
Biogen, Inc.
$19
GENZYME CORPORATION
$17
Lilly USA, LLC
$15
Saol Therapeutics Inc.
$15
Promius Pharma LLC
$14
ARBOR PHARMACEUTICALS, INC.
$12
Scilex Pharmaceuticals Inc.
$11
Greenwich Biosciences, Inc.
$11
US WorldMeds, LLC
$11
Top 3 companies account for 29.5% of all-time payments
Associated products mentioned in payments ›
ACTIVA · ADUHELM · AIMOVIG · AMPYRA · AMYVID · ANDEXXA · APTIOM · Aduhelm · Aimovig · BOTOX · BOTOX THERAPEUTIC · BRILINTA · Briviact · CARDIOFORM Septal Occluder · Cardiac Monitoring Suite · DIVIGEL · DYSPORT · Dhivy · Dysport · Epidiolex · Fycompa · GOCOVRI · Gamunex-C · Hizentra · Horizant · INBRIJA · INGREZZA · KESIMPTA · LEMTRADA · LINZESS · MAVENCLAD · MIGRANAL · NORTHERA · NUPLAZID · NURTEC ODT · Neupro · Nourianz · Nuedexta · ONFI · Ongentys · PANZYGA · QULIPTA · Qutenza · RYTARY · SOLIRIS · Soliris · UBRELVY · ULTOMIRIS · UPLIZNA · VALTOCO · VYEPTI · VYVGART · XEOMIN · Xadago · Xeomin · ZTLido 30 POUCH in 1 CARTON 1 PATCH in 1 POUCH · Zembrace
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Neurologists within 10 mi
215
Per 100K population
14.1
County median income
$128,329
Nearest hospital
NS/LIJ HS SOUTHSIDE HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Mebrahtu is a clinical cardiology specialist, with above-average Medicare volume (top 17% in NY), with low-engagement industry engagement, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Mebrahtu experienced with electromyography of arm or leg muscles?
Based on Medicare claims data, Dr. Mebrahtu performed 508 electromyography of arm or leg muscles services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Mebrahtu receive payments from pharmaceutical companies?
Yes. Dr. Mebrahtu received a total of $3,898 from 52 companies across 198 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Mebrahtu's costs compare to other neurologists in Bay Shore?
Dr. Mebrahtu's average Medicare payment per service is $110. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Mebrahtu) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Neurology
Common procedures, typical costs, and what industry payments mean in neurology.
Same specialty & city
Neurologists in Bay Shore
Browse neurologists in Bay Shore ranked by procedure volume and transparency data.
Highest volume
Top Neurologists in NY
Neurologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Neurologists in NY
Which NY neurologists receive the most from drug and device companies.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
Alexion Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Alexion Pharmaceuticals, Inc.
By company
UCB, Inc. Payments to Doctors
See all physicians who received payments from UCB, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology